GPC1 and pancreatic neoplasm: Three cancer‐correlated biomarkers (epidermal growth factor receptor (EGFR), one pancreatic cancer marker (glypican‐1, GPC1) and macrophage migration inhibitory factor (MIF)) can be detected by the developed MAIP‐based platform with a detection limit as low as 5 pg mL−1.